NCT05660954 2025-09-05CABOTHYROIDGrupo Espanol de Tumores NeuroendocrinosPhase 2 Active not recruiting41 enrolled
NCT03630120 2021-07-14Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated6 enrolled 9 charts